Lipika Goyal, Haley Ellis, Mitesh Borad, Richard D. Kim, Jordi Rodon Ahnert, Alexander Starodub, Juan W. Valle, John Bridgewater, Jeffery Russell, Akza Ali, Kevin Moynihan, Meredith Little, Liangxing Zou, Julia Lawrence, Arndt Vogel. "A first-in-human multi-center phase 1/2 study of a selective FGFR2/3 inhibitor, CGT4859, in patients with intrahepatic cholangiocarcinomas or other advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps3171